Targacept Stock Price Down 10.3% on Disappointing Earnings (TRGT)
Shares of Targacept (NASDAQ:TRGT) were down 10.3% on Wednesday after the company announced weaker than expected quarterly earnings, Analyst Ratings Network reports. The company traded as low as $3.81 and last traded at $3.84, with a volume of 167,099 shares trading hands. The stock had previously closed at $4.28.
The company reported ($0.44) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.37) by $0.07. The company had revenue of $0.09 million for the quarter, compared to the consensus estimate of $3.54 million. During the same quarter in the prior year, the company posted ($0.24) earnings per share. The company’s quarterly revenue was down 97.5% on a year-over-year basis.
The stock’s 50-day moving average is $4.49 and its 200-day moving average is $4.71. The company’s market cap is $138.7 million.
Targacept, Inc is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.